VP Global Head of Respiratory, Allergy & Infectious Disease Product Development
Genentech, Inc.
South San Francisco, California
Larry Tsai, MD, is the Global Head for Respiratory, Allergy, and Infectious Diseases, Product Development, at Genentech, A Member of the Roche Group. He has been closely involved in the company's pandemic-related efforts, including the development of host-directed therapies for severe COVID. Prior to joining Genentech in 2019, Larry served as Chief Medical Officer of Tetraphase Pharmaceuticals, developing treatments for multidrug-resistant bacterial infections. He is a board certified Internist and Pulmonary and Critical Care physician with over 20 years of experience as a clinician, educator, researcher, and drug developer.
Repurposing Host-Directed Therapeutics for COVID-19
Sunday, January 21, 2024
11:50 AM – 12:00 PM MT